Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Movassat, J.
Right arrow Articles by Portha, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Movassat, J.
Right arrow Articles by Portha, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 9 1445-1452, Copyright © 1997 by American Diabetes Association


ARTICLES

Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats

J Movassat, C Saulnier and B Portha
Laboratory of Physiopathology of Nutrition, Universite Paris, France.

We have previously reported that the damage caused by streptozotocin (STZ) administration to the beta-cells in newborn rats was followed by spontaneous recovery from neonatal diabetes. Our present data indicate that STZ administration on the day of birth (day 1) reduced the total beta-cell mass on day 4 to only 10% of the normal value and that after such damage, 27% of the corresponding normal beta-cell mass was spontaneously regained on day 7. During days 4-7, the contribution of the predicted beta-cell growth (due to the replication of preexisting differentiated beta-cells) to the total beta-cell growth represented only 56%. Therefore, recruitment of new beta-cells from a precursor pool indeed represents a significant mechanism for beta-cell regeneration after STZ during this period of life. Here, we report for the first time that 1) insulin therapy from days 2 to 4 did not significantly influence the occurrence of beta-cell damage after STZ administration (total beta-cell mass on day 4 was reduced to 12% of the normal value) and 2) insulin therapy from days 2 to 6 did improve the otherwise spontaneous beta-cell regeneration, since on day 7 total beta-cell mass was 44% of the corresponding normal beta-cell mass. During days 4-7, the contribution of the predicted beta-cell growth to the total beta-cell growth represented only 32% in the insulin-treated STZ group. Finally the insulin-favored regeneration of the beta-cells reflects both an increased replication from differentiated beta-cells and an increased neogenesis from precursor/stem cells, with this last pathway being preferentially activated.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J EndocrinolHome page
J. Movassat and B. Portha
Early administration of keratinocyte growth factor improves {beta}-cell regeneration in rat with streptozotocin-induced diabetes
J. Endocrinol., November 1, 2007; 195(2): 333 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Fernandez, M. A. Martin, S. Fajardo, D. Bailbe, M. N. Gangnerau, B. Portha, F. Escriva, P. Serradas, and C. Alvarez
Undernutrition does not alter the activation of beta-cell neogenesis and replication in adult rats after partial pancreatectomy
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E913 - E921.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Thyssen, E. Arany, and D. J. Hill
Ontogeny of Regeneration of {beta}-Cells in the Neonatal Rat after Treatment with Streptozotocin
Endocrinology, May 1, 2006; 147(5): 2346 - 2356.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Li, Z. Yi, M. Seno, and I. Kojima
Activin A and Betacellulin: Effect on Regeneration of Pancreatic {beta}-Cells in Neonatal Streptozotocin-Treated Rats
Diabetes, March 1, 2004; 53(3): 608 - 615.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Paris, C. Bernard-Kargar, M.-F. Berthault, L. Bouwens, and A. Ktorza
Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic {beta}-Cell Mass in Vivo in Adult Rats
Endocrinology, June 1, 2003; 144(6): 2717 - 2727.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. N. Friedrichsen, H. E. Richter, J. A. Hansen, C. J. Rhodes, J. H. Nielsen, N. Billestrup, and A. Moldrup
Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells
Mol. Endocrinol., May 1, 2003; 17(5): 945 - 958.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Tourrel, D. Bailbe, M. Lacorne, M.-J. Meile, M. Kergoat, and B. Portha
Persistent Improvement of Type 2 Diabetes in the Goto-Kakizaki Rat Model by Expansion of the {beta}-Cell Mass During the Prediabetic Period With Glucagon-Like Peptide-1 or Exendin-4
Diabetes, May 1, 2002; 51(5): 1443 - 1452.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Li, M. Seno, H. Yamada, and I. Kojima
Promotion of {beta}-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats
Endocrinology, December 1, 2001; 142(12): 5379 - 5385.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Tourrel, D. Bailbe, M.-J. Meile, M. Kergoat, and B. Portha
Glucagon-Like Peptide-1 and Exendin-4 Stimulate {beta}-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age
Diabetes, July 1, 2001; 50(7): 1562 - 1570.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. BERNARD, M.-F. BERTHAULT, C. SAULNIER, and A. KTORZA
Neogenesis vs. apoptosis as main components of pancreatic ß cell mass changes in glucose-infused normal and mildly diabetic adult rats
FASEB J, July 1, 1999; 13(10): 1195 - 1205.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. T. Finegood, G. C. Weir, and S. Bonner-Weir
Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats
Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E822 - E827.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.